Fair Money & Economic Opportunity

M3V.XETRA (MEVIS MEDICAL SOLUTIONS AG) is a medical technology company specializing in image processing software.

The provided articles do not contain any specific, concrete data points or information regarding M3V.XETRA's involvement in financial services, lending, or any activities relevant to the 'Fair Money & Economic Opportunity' value. Therefore, no KPIs can be scored based on the evidence provided.

Fair Pay & Worker Respect

MeVis Medical Solutions has an overall employee rating of 3.7 out of 5, which translates to approximately 74% for worker engagement.

Employee reviews indicate specific concerns regarding senior management (2.3/5), compensation and benefits (2.5/5), and career opportunities (1.9/5). No quantitative data is available for living wage coverage, CEO-median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage.

Fair Trade & Ethical Sourcing

MeVis Medical Solutions AG is a medical technology company focused on developing and marketing image processing software.

Its primary business model involves software development and services, not the procurement or trade of physical commodities. Therefore, all KPIs related to fair trade certifications, supplier audits, forced/child labor incidents in the supply chain, supply chain traceability, remediation speed for sourcing violations, ethical clauses in supplier contracts, high-risk materials, and supplier diversity spend are not applicable to its operations. No evidence was found in the provided articles to suggest the company engages in activities that would require scoring against these specific supply chain and sourcing metrics.

Honest & Fair Business

The company has a formal whistleblower policy, connected to Varex Group's external system, which details reporting modes, confidentiality, and protection of reporters, and complies with EU and Italian regulations.

However, there is no explicit evidence of independent investigation processes. For non-anonymous reports, acknowledgment is within 7 days, but feedback can take up to 90 days. Annual financial statements are audited by Deloitte GmbH in accordance with German generally accepted standards, covering the company's financial statements. The Supervisory Board does not include any independent members due to majority shareholder control. A compliance guideline is binding for all employees, published on the intranet, and supported by continuous compliance training, but lacks specific details on enforcement effectiveness or risk-based customization. The quality management system is certified by DNV MEDCERT GmbH for medical device software development, production, and distribution, and for services in accordance with EN ISO 13485:2016 and MDSAP Audit Model Edition 2, which covers a significant portion of its ethical claims related to product quality and regulatory compliance.

Kind to Animals

No evidence was found in the provided articles to assess MEVIS MEDICAL SOLUTIONS AG against any of the 'Kind to Animals' KPIs. The articles either pertain to different companies or discuss general corporate compliance and sustainability without specific data points regarding animal welfare, animal testing, animal-derived ingredients, animal agriculture, or wildlife conservation initiatives for MEVIS MEDICAL SOLUTIONS AG.

Therefore, all KPIs are omitted due to a lack of explicit evidence.

No War, No Weapons

The company, MeVis Medical Solutions AG, operates in the medical technology sector, specializing in image processing software for cancer screening and diagnosis.

The provided articles consistently state that the company's activities related to all 'No War, No Weapons' KPIs are 'Not applicable' because it is in the medical technology sector. This indicates that the company has no defense or arms-related activities in its core business, no dual-use technology, no sales to embargoed regimes, no peacebuilding investments, no conflict divestment policy, no board oversight of defense, no export end-user certificates, no lobbying related to arms control, no humanitarian procurement compliance issues, no HR due diligence in conflict areas, no Arms Trade Treaty compliance declarations, no AI military safeguards, no UNGP alignment issues related to conflict, no dual-use items to screen, no surveillance or intelligence activities, no ethical red lines needed for weapons, no exposure to controversial weapons, no war-related supply chain risk audits, no annual conflict partner reviews, no defense-related assets to divest, no conflict minerals in its supply chain, no peace technology investment ratio to calculate against military tech, no procurement from conflict-affected areas, and no ethical red lines compliance rate for weapons. Therefore, all relevant KPIs are scored at 0, indicating N/A due to the nature of its core business.

Respect for Cultures & Communities

The provided articles, which focus on corporate governance, compliance, and career opportunities, do not contain any specific data or information relevant to the company's respect for cultures and communities. The reports explicitly state a lack of quantitative data regarding formal partnerships with community groups, revenue reinvested in local development, cultural appropriation incidents, cultural impact assessment protocols, local employment ratios, community grievance mechanisms, indigenous relations, cultural preservation, language inclusivity, or social license to operate.

Therefore, no KPIs under this value can be scored based on the evidence provided.